A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new TACE-prognostic (TP) score helps predict overall survival for hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE). This validated model identifies patients who will benefit most from TACE treatment.
Area Of Science
- Hepatology
- Oncology
- Medical Imaging
Background
- Transarterial chemoembolization (TACE) is a primary treatment for hepatocellular carcinoma (HCC).
- Patient stratification is crucial to identify individuals who will most benefit from TACE.
- Existing models require refinement for predicting overall survival (OS) in HCC patients undergoing TACE.
Purpose Of The Study
- To develop and validate a refined prediction model for OS in HCC patients receiving first-line TACE.
- To create a prognostic scoring system for stratifying patients based on predicted outcomes.
Main Methods
- A cohort of 2,632 HCC patients (Barcelona Clinic Liver Cancer stage A or B) treated with TACE was divided into training (n=1,304) and validation (n=1,328) groups.
- Independent predictors of OS were identified to construct a new prediction model.
- The TACE-prognostic (TP) score was developed using tumor burden, alpha-fetoprotein, and Albumin-Bilirubin grade.
Main Results
- The TP score, incorporating tumor burden, alpha-fetoprotein, and Albumin-Bilirubin grade, was developed.
- Patients were categorized into five risk groups based on TP scores, showing significant differences in median survival in both cohorts (P < 0.001).
- The TP score model demonstrated superior performance compared to existing models in both training and validation datasets.
Conclusions
- The TP scoring system shows potential as a valuable tool for identifying suitable TACE candidates and predicting OS.
- The model offers favorable performance and discrimination for patient stratification.
- Further external validation is recommended to confirm the TP score's effectiveness.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
